Brucellosis

Brucellosis is a serious bacterial infection caused by Brucella canis that primarily affects the reproductive system of dogs. This contagious disease represents one of the most significant concerns in canine breeding operations due to its ability to cause reproductive failure, including spontaneous abortions in pregnant females and infertility in both sexes. The condition is considered endemic in many parts of the world and poses particular challenges because infected dogs can remain carriers for extended periods, often without showing obvious clinical signs. Canine brucellosis is a reportable disease in many jurisdictions due to its potential impact on both animal and public health.

The Brucella canis bacterium is transmitted primarily through sexual contact, making intact breeding dogs the most at-risk population. However, transmission can also occur through contact with infected bodily fluids including aborted materials, vaginal discharges, semen, and even urine. The bacteria enter the body through mucous membranes and quickly spread through the lymphatic system to various organs, with particular affinity for reproductive tissues. Once established, the infection can persist for years, with the dog continuously shedding bacteria and remaining infectious to other animals and potentially to humans.

The impact of brucellosis on affected dogs and breeding programs cannot be overstated. Infected females typically experience late-term abortions, usually between 45 and 59 days of gestation, though early embryonic death and resorption can also occur. Male dogs develop epididymitis and orchitis, leading to testicular atrophy and permanent infertility. Beyond reproductive consequences, the bacteria can cause diskospondylitis, affecting the spine and causing significant pain and neurological symptoms in some cases. The chronic nature of infection means that even dogs that appear healthy may harbor and spread the disease.

Treatment of canine brucellosis presents significant challenges, and complete elimination of the bacteria is often impossible despite prolonged antibiotic therapy. Many veterinary experts recommend surgical sterilization combined with long-term antibiotics as the most practical approach to managing infected animals. Prevention through regular testing of breeding dogs remains the cornerstone of control efforts, as early detection and removal of infected animals from breeding programs is essential. Due to the zoonotic potential of Brucella canis, owners handling infected dogs should take appropriate precautions, and veterinary guidance is absolutely essential for any suspected cases.

Canine brucellosis is caused exclusively by the bacterium Brucella canis, a small gram-negative coccobacillus that has evolved specifically to infect dogs. This pathogen belongs to the Brucella genus, which includes several species affecting different animal hosts, but B. canis demonstrates a strong preference for canine tissues. The bacterium possesses unique characteristics that allow it to survive and replicate within host cells, particularly macrophages, effectively hiding from the immune system and enabling chronic, persistent infection. Understanding the nature of this pathogen is essential for appreciating why brucellosis is so difficult to eliminate once established.

Sexual transmission represents the primary route of infection for Brucella canis in dog populations. During breeding, the bacterium is readily transmitted through infected semen or vaginal secretions, making intact breeding dogs the highest-risk group. A single mating with an infected animal can result in transmission, and the bacteria are shed in particularly high concentrations during and after reproductive events. Male dogs shed organisms in semen for months to years following infection, while females shed heavily during estrus and following abortion or whelping. This mode of transmission explains why brucellosis outbreaks are most commonly associated with breeding kennels and facilities.

Beyond sexual contact, several other transmission routes facilitate the spread of brucellosis. Contact with aborted fetuses, placentas, and vaginal discharges from infected females exposes other dogs to massive bacterial loads. The bacteria can also be transmitted through contaminated urine, as infected dogs shed organisms intermittently in their urine for extended periods. Oral transmission occurs when dogs lick or ingest infected materials, and the bacteria readily penetrate the mucous membranes of the mouth, nose, and eyes. Sharing of contaminated equipment, bedding, or living spaces can also facilitate indirect transmission between dogs.

Once Brucella canis enters the body, it quickly disseminates through the bloodstream and lymphatic system. The bacteria show tropism for reproductive tissues, lymph nodes, and the intervertebral disks of the spine. Within target organs, the bacteria are engulfed by macrophages but have developed mechanisms to survive and replicate within these immune cells. This intracellular lifestyle protects the bacteria from antibodies and many antimicrobial drugs, contributing to the chronicity of infection. The immune response generates antibodies that can be detected on testing, but these antibodies are insufficient to clear the infection.

Several risk factors increase the likelihood of brucellosis transmission and establishment. Dogs in breeding facilities with inadequate testing protocols face the highest risk, particularly when new dogs are introduced without proper quarantine and screening. Stray and feral dog populations serve as reservoirs of infection in many areas. Dogs with access to wildlife or feral dog populations may also be exposed. The bacteria can survive in the environment for weeks to months under favorable conditions, meaning contaminated facilities pose ongoing transmission risks until properly decontaminated.

The clinical presentation of canine brucellosis varies considerably between individual dogs, with some animals showing obvious reproductive failure while others remain apparently healthy despite being infected and infectious. This variability in symptom expression contributes to the insidious nature of the disease and its ability to spread undetected through breeding populations. Recognizing the range of possible symptoms is crucial for early detection and intervention, though it must be emphasized that many infected dogs show minimal outward signs of illness for extended periods.

Reproductive failure represents the hallmark symptom of brucellosis in female dogs. The most characteristic presentation is late-term abortion, typically occurring between 45 and 59 days of gestation when puppies are partially developed but not yet viable. These abortions often produce partially autolyzed fetuses, as bacterial infection causes fetal death days before expulsion. Some infected females experience earlier pregnancy loss through embryonic resorption, which may go unnoticed or be attributed to breeding failure. Following abortion, affected females typically have prolonged vaginal discharge that is highly infectious. Subsequent breeding attempts often result in repeated pregnancy loss or conception failure.

Male dogs with brucellosis develop characteristic changes in their reproductive organs that progress over time. Epididymitis, inflammation of the epididymis, typically appears first and may cause visible scrotal swelling and discomfort. This progresses to orchitis with testicular enlargement followed by gradual atrophy as the inflammatory process destroys testicular tissue. Affected males may show decreased libido and reluctance to breed. Sperm abnormalities become apparent on semen evaluation, including decreased motility, increased morphological defects, and eventually azoospermia as testicular function deteriorates. These changes are usually irreversible, resulting in permanent infertility.

Beyond reproductive symptoms, brucellosis can cause systemic illness affecting multiple body systems. Lymphadenopathy, or enlargement of lymph nodes, commonly affects nodes throughout the body and may be detected during physical examination. Some dogs develop diskospondylitis, a painful infection of the intervertebral disks and adjacent vertebral bodies that can cause back pain, reluctance to move, and neurological deficits depending on severity and location. Uveitis and other eye inflammation can occur, potentially threatening vision. Lethargy and exercise intolerance may develop, though many infected dogs maintain apparently normal energy levels.

It is critically important to recognize that many dogs with brucellosis appear completely healthy despite active infection. These asymptomatic carriers pose the greatest risk to breeding populations because they can transmit infection without raising suspicion. Dogs may remain clinically normal for months to years while continuously shedding bacteria in bodily fluids. The intermittent nature of bacterial shedding and the lack of consistent symptoms mean that repeated testing is necessary to identify infected animals. Some dogs eventually clear visible symptoms while remaining chronically infected.

Owners and breeders should be alert to several warning signs that warrant immediate veterinary investigation. Any unexplained pregnancy loss, particularly late-term abortion, should prompt brucellosis testing. Male dogs showing scrotal swelling, testicular changes, or declining fertility require evaluation. Back pain or stiffness, especially in breeding dogs, may indicate diskospondylitis. Chronic or recurrent eye inflammation should raise suspicion. Any dog with a history of exposure to known or suspected positive animals needs comprehensive testing. Given the serious implications of this disease, erring on the side of caution with testing is always appropriate.

Accurate diagnosis of canine brucellosis requires a systematic approach combining clinical evaluation with specific laboratory testing, as the variable presentation of this disease makes clinical diagnosis alone unreliable. Veterinarians experienced with brucellosis understand that multiple testing modalities may be necessary, and interpretation requires consideration of the dog's history, clinical signs, and epidemiological context. Early and accurate diagnosis is essential not only for the individual animal but for protecting other dogs and preventing further spread of this highly contagious disease.

Initial veterinary evaluation begins with thorough history taking and physical examination. The veterinarian will inquire about breeding history, including any reproductive failures, abortions, or fertility problems. Recent breeding activities and exposure to new or untested dogs are particularly relevant. Physical examination may reveal lymphadenopathy, testicular abnormalities in males, or evidence of diskospondylitis. However, many infected dogs have completely normal physical examinations, reinforcing the need for laboratory confirmation. The veterinarian will also assess for any signs of systemic illness that might suggest chronic infection.

Serological testing forms the backbone of brucellosis diagnosis and involves detecting antibodies produced in response to infection. The rapid slide agglutination test (RSAT) is commonly used as an initial screening test due to its speed and relatively low cost. Positive RSAT results require confirmation with more specific tests, as false positives can occur. The tube agglutination test (TAT) provides more reliable results and can be semiquantitative. Agar gel immunodiffusion (AGID) testing is highly specific and useful for confirming infection. It is important to understand that antibodies may not be detectable during early infection, necessitating repeat testing of exposed dogs.

Bacterial culture provides definitive diagnosis by isolating Brucella canis from clinical samples. Blood culture during bacteremic episodes can yield positive results, though bacteremia may be intermittent in chronically infected dogs. Culture of semen, vaginal discharge, or tissues from aborted materials often provides higher yield. Culture of lymph node aspirates may be diagnostic. However, bacterial culture requires specialized laboratory facilities due to the biohazard risk Brucella poses to laboratory personnel. Polymerase chain reaction (PCR) testing offers another option for detecting bacterial DNA and may be particularly useful when culture facilities are unavailable or when rapid results are needed. Negative test results do not definitively rule out infection, and veterinarians may recommend repeat testing over time for dogs with suspicious histories or known exposures.

Treatment of canine brucellosis presents significant challenges that owners must understand from the outset. Unlike many bacterial infections that can be cured with appropriate antibiotics, Brucella canis resides within host cells where antimicrobial drugs have limited penetration, making complete elimination of the bacteria extremely difficult or impossible. Treatment decisions must balance the desire to help the individual animal against the ongoing risk of transmission to other dogs and the zoonotic potential for human infection. Veterinary guidance is essential for navigating these complex considerations.

Antibiotic therapy forms the foundation of brucellosis treatment, though expectations must be realistic about outcomes. Combination antibiotic protocols are typically employed because single-drug therapy has proven inadequate for eliminating intracellular bacteria. Common regimens include tetracyclines (such as doxycycline or minocycline) combined with aminoglycosides (such as streptomycin or gentamicin). Treatment courses are prolonged, often lasting several weeks to months, and may need to be repeated. Even with aggressive antibiotic therapy, complete bacterial elimination is rarely achieved, and treated dogs often experience relapse or remain carriers capable of transmitting infection.

Surgical sterilization is strongly recommended for all dogs diagnosed with brucellosis, serving both therapeutic and preventive purposes. In females, ovariohysterectomy removes the primary target organs for bacterial colonization and eliminates the possibility of future pregnancy loss and associated shedding of infectious materials. In males, castration removes infected testicular tissue that serves as a bacterial reservoir and prevents transmission through breeding. Sterilization significantly reduces bacterial shedding and decreases the risk of transmission to other animals. Many experts consider spay or neuter an essential component of any brucellosis management protocol.

Post-treatment monitoring is critical for assessing response and detecting relapse. Serological testing should be performed at regular intervals following treatment completion, with decreasing antibody titers suggesting some degree of immune response. However, titers may remain positive indefinitely even in dogs that appear clinically healthy. Periodic blood cultures or PCR testing may help assess ongoing infection status. Clinical monitoring for recurrence of symptoms, particularly reproductive issues in any intact dogs or signs of diskospondylitis, continues long-term. Owners must understand that treated dogs should be considered potentially infectious indefinitely.

The decision whether to treat or euthanize an infected dog involves complex considerations. For valuable breeding animals, the loss of reproductive capability through sterilization eliminates their purpose. The ongoing risk of transmission to other dogs and potentially to humans must be weighed carefully. Some owners elect humane euthanasia, particularly for dogs with severe clinical signs or in situations where isolation from other dogs cannot be guaranteed. For pet dogs in single-dog households with committed owners, treatment combined with sterilization may be reasonable if appropriate precautions are taken.

Supportive care addresses symptoms while antibiotic therapy works to reduce bacterial burden. Dogs with diskospondylitis may require pain management and anti-inflammatory medications, along with activity restriction to prevent spinal damage. Nutritional support helps maintain body condition during prolonged treatment. Eye inflammation requires appropriate ophthalmic therapy. Rest and reduced activity are generally recommended during active treatment phases. Throughout treatment, infected dogs must be strictly isolated from other dogs to prevent transmission, and owners should take precautions including glove use when handling the dog or cleaning up bodily fluids.

Recovery from canine brucellosis differs fundamentally from recovery following most infectious diseases, as true cure or complete bacterial elimination is rarely if ever achieved. Instead, the goal of treatment is to reduce clinical symptoms, decrease bacterial shedding, and manage the disease as a chronic condition. Owners must adjust their expectations accordingly and understand that their dog will require lifelong monitoring and management. This reality, while challenging, allows many affected dogs to enjoy good quality of life with appropriate care and precautions.

The timeline for clinical improvement varies depending on the severity of symptoms at diagnosis. Dogs with acute reproductive symptoms may show improvement within weeks of initiating treatment, with reduction in vaginal discharge or scrotal swelling. Resolution of systemic symptoms such as lethargy and lymphadenopathy typically occurs over several weeks to months. Diskospondylitis, when present, requires prolonged treatment and may leave residual effects depending on the degree of spinal damage before diagnosis. Following surgical sterilization, recovery from surgery itself follows normal timelines of one to two weeks for routine healing, though antibiotic therapy continues well beyond this period.

Long-term prognosis for brucellosis-affected dogs depends on several factors. Dogs diagnosed and treated early, before significant organ damage occurs, generally fare better than those with advanced disease. The presence or absence of diskospondylitis significantly affects prognosis, as spinal involvement can cause chronic pain and neurological deficits. Age and overall health status influence the dog's ability to tolerate prolonged treatment and potential side effects. Perhaps most importantly, the owner's ability to maintain isolation, follow treatment protocols, and continue monitoring determines practical outcomes. Dogs that can be kept safely separated from other dogs and whose owners practice appropriate hygiene have the best outlook.

Ongoing care requirements for brucellosis survivors include regular veterinary rechecks and periodic testing to monitor disease status. Serological testing at intervals recommended by the veterinarian helps track antibody levels, though interpretation requires expertise. Any recurrence of symptoms warrants immediate veterinary attention and potentially additional treatment courses. The dog should never be bred or have contact with intact dogs, even after treatment. Owners must maintain awareness of the zoonotic risk and continue hygiene precautions indefinitely. With dedicated management, many dogs with brucellosis live comfortably for years, though they require more intensive care than healthy dogs and can never be considered free of infection.

Prevention of canine brucellosis centers on testing and biosecurity measures, as no vaccine is currently available for this disease. For breeding operations, prevention is not merely advisable but essential, given the devastating impact an outbreak can have on a breeding program. Individual pet owners can also take steps to protect their dogs, particularly when considering breeding or acquiring new animals. Understanding and implementing preventive strategies represents the most effective approach to this challenging disease.

Routine testing of breeding dogs forms the cornerstone of brucellosis prevention in responsible breeding programs. All dogs should be tested negative before any breeding occurs, regardless of their previous testing history. Testing should be performed within 30 days prior to breeding to ensure current status, as dogs can become infected between annual tests. Both the male and female in any breeding pair should be tested, with no exceptions made for seemingly healthy animals. Repeat testing at regular intervals, typically every six to twelve months for active breeding dogs, helps catch infections that may occur between breeding events. Test results should be documented and available for prospective puppy buyers.

Biosecurity protocols in breeding facilities significantly reduce transmission risk. New dogs entering a facility should be quarantined and tested before introduction to the general population. A quarantine period of at least 30 days with testing at the beginning and end helps ensure dogs are not incubating infection. Limiting exposure to outside dogs, including at dog shows or breeding facilities, reduces the chance of introducing infection. Strict sanitation of breeding areas and equipment between uses prevents environmental transmission. Facilities should have protocols in place for immediate isolation and testing if any dog shows suspicious symptoms.

For individual pet owners, prevention focuses on avoiding exposure and testing before any breeding activity. Dogs from unknown or untested sources should be tested for brucellosis regardless of intended use. Avoiding contact between intact dogs and stray or unknown dogs reduces exposure risk. Owners considering breeding their dogs should require current negative brucellosis tests from any proposed breeding partner. Purchasing puppies from breeders who test all breeding stock provides some assurance, though puppies can be infected from positive dams.

Public health considerations add another dimension to brucellosis prevention. Brucella canis is zoonotic, meaning it can infect humans, though human cases are relatively uncommon. People with compromised immune systems, pregnant women, and those in close contact with infected dogs face the highest risk. Hand hygiene after handling dogs, especially around breeding activities or sick animals, provides basic protection. Anyone experiencing flu-like symptoms after exposure to dogs, particularly in breeding settings, should inform their physician of the potential exposure. These considerations underscore the importance of preventing canine brucellosis not just for animal health but for human health as well.

Living with a brucellosis-positive dog requires significant lifestyle adjustments and ongoing commitment from owners. While the diagnosis is serious, many affected dogs can enjoy reasonable quality of life with appropriate management. The key challenges involve preventing transmission to other animals, protecting human household members from zoonotic infection, and maintaining the dog's health through long-term medical management. Success depends on owner dedication, veterinary partnership, and realistic expectations about the limitations and responsibilities involved.

Daily management of a brucellosis-positive dog begins with strict isolation from other dogs. The infected dog must be the only dog in the household, or if other dogs are present, complete physical separation must be maintained at all times. This means separate living areas, separate outdoor spaces, and no shared food or water bowls, bedding, or toys. Even dogs that have been treated and appear healthy continue to shed bacteria intermittently and must be considered infectious indefinitely. For many owners, this requirement alone determines whether keeping a brucellosis-positive dog is feasible.

Hygiene practices protect human household members from zoonotic transmission. Owners should wear gloves when cleaning up after the dog, handling bodily fluids, or cleaning bedding and living areas. Thorough handwashing after any contact with the dog is essential. Avoiding contact between the dog's saliva and any cuts or mucous membranes reduces transmission risk. While Brucella canis infections in humans are relatively rare and usually mild, immunocompromised individuals, pregnant women, young children, and elderly persons face higher risk and should minimize contact with infected animals. Some families may determine that the zoonotic risk is incompatible with their household composition.

Medication management requires consistency and attention to detail. Long-term or repeated antibiotic courses must be administered exactly as prescribed, with attention to timing, dosing, and completion of full treatment courses. Owners should maintain detailed records of medications given and any observed side effects. Regular veterinary appointments for monitoring and repeat testing must be prioritized. The cost of ongoing medication and veterinary care can be substantial over time, and owners should consider whether they can sustain this financial commitment.

Maintaining quality of life for a brucellosis-positive dog involves balancing necessary restrictions with enrichment and enjoyment. While contact with other dogs must be avoided, the dog can still enjoy walks in areas where encounters with other dogs can be prevented. Mental stimulation through training, puzzle toys, and owner interaction helps compensate for reduced social opportunities. Appropriate exercise maintains physical health and provides stress relief. Owners should focus on providing a loving, comfortable home environment while recognizing that some normal dog activities will no longer be possible. Regular communication with the treating veterinarian helps address any concerns and adjust management strategies as needed over time.

Canine brucellosis does not show breed predisposition in the traditional sense of genetic susceptibility. Unlike many diseases where certain breeds are inherently more vulnerable due to their genetic makeup, brucellosis affects dogs of all breeds equally when exposed to the Brucella canis bacterium. Instead, risk correlates primarily with lifestyle factors, particularly involvement in breeding activities and exposure opportunities. Understanding which populations face higher risk helps target prevention efforts where they are most needed.

Breeding dogs of any breed constitute the highest-risk population for brucellosis. Because sexual transmission is the primary route of infection, intact dogs used for breeding have the greatest exposure opportunity. This risk is particularly elevated in commercial breeding operations, puppy mills, and facilities where dogs from multiple sources are brought together for breeding without adequate testing protocols. Breeds that are commonly used in high-volume breeding operations may appear to have higher incidence simply due to population dynamics rather than breed susceptibility. Purebred dogs used in breeding programs and mixed-breed dogs in informal breeding situations share equal susceptibility to infection.

Certain populations and situations create elevated risk regardless of breed. Dogs obtained from shelters, rescues, or stray populations have unknown histories and potential exposure. Dogs imported from regions with high brucellosis prevalence require careful screening. Dogs in rural areas with exposure to feral dog populations face increased risk. Hunting dogs that may contact wildlife or feral dogs represent another at-risk group. Male dogs used as stud dogs traveling to breed with multiple females have repeated exposure opportunities. Conversely, neutered pet dogs in single-dog households with no contact with intact dogs face minimal risk regardless of breed, as they lack the exposure opportunities that drive transmission.

Understanding conditions related to canine brucellosis helps owners and veterinarians recognize the broader context of this disease and its potential complications. Some conditions may present similarly and require differentiation, while others may develop as consequences of brucellosis infection. Awareness of these relationships supports more comprehensive care and appropriate diagnostic approaches.

Several reproductive conditions may be confused with brucellosis or require differentiation during diagnosis. Other causes of pregnancy loss in dogs include canine herpesvirus, which typically causes neonatal death rather than late-term abortion, hypothyroidism, nutritional deficiencies, and non-infectious uterine abnormalities. Pyometra, a life-threatening uterine infection, can cause vaginal discharge and systemic illness but has different bacterial causes and treatment approaches. Male infertility can result from numerous conditions beyond brucellosis, including prostatic disease, testicular tumors, and hormonal imbalances. Veterinary evaluation helps distinguish between these conditions through appropriate testing.

Diskospondylitis from causes other than brucellosis can produce similar spinal symptoms. Other bacterial species, including Staphylococcus, Streptococcus, and Escherichia coli, can cause vertebral infections. Fungal diskospondylitis occurs in some geographic regions. Degenerative spinal conditions, intervertebral disk disease, and spinal tumors may present with comparable pain and neurological signs. Differentiating brucellosis-related diskospondylitis from these other causes requires combining spinal imaging with brucellosis-specific testing. Additionally, systemic brucellosis can lead to secondary complications including chronic immune-mediated conditions, and the prolonged antibiotic therapy required for treatment may predispose to opportunistic infections or antibiotic-resistant bacterial problems.